Clinical trial
Multicenter, Double Blind, Randomized Dose Finding Study in Myocardial Perfusion MRI With Gadavist®1.0
NCT01490294 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter, Double Blind, Randomized Dose Finding Study in Myocardial Perfusion MRI With Gadavist®1.0
- Lead sponsor
- Bayer
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 31, 2004
- Completion date
- May 31, 2006
- Enrollment
- 232 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
magnetic resonance imaging, myocardial perfusion imaging